Journal
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
Volume 68, Issue 6, Pages 763-767Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPG.0000000000002333
Keywords
clinically evident ascites; definitions; gastroesophageal; portal hypertension; splenomegaly; varices
Funding
- National Institute of Diabetes, Digestive and Kidney Diseases [DK 62445, DK62497, DK 62470, DK 62481, DK 62456, DK 84536, DK 84575, DK 62500, DK 62503, DK 62466, DK 62453, DK 62452, DK 84538, DK 62436, DK103149, DK103135, DK103140]
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062470, U01DK062481, U01DK084538, U01DK062436, U01DK062456, U01DK084575, U01DK062466, U01DK062497, U01DK103149, U01DK062500, U01DK103135, U01DK084536, U01DK103140, U01DK062453] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Portal hypertension (PHT) is a major cause of morbidity and mortality in pediatric liver diseases. Thus, research into causes and disease modifiers in PHT in these conditions is vitally important. PHT is rarely directly or indirectly measured in the assessment of children with chronic liver disease. A straightforward, reproducible definition of PHT could be invaluable for consistently identifying patients with PHT and for grouping these patients according to their risk of complications from their disease. We propose the term Clinically Evident Portal Hypertension (CEPH) to denote clinical findings that demonstrate evidence of elevated portal pressure. When CEPH criteria are met, PHT is highly likely to be present, although it is likely that PHT exists for variable periods of time before meeting CEPH criteria. Use of this research definition of CEPH will allow for consistent identification of these patients by clinicians in nearly any clinical setting and serve as a clinical milepost that may dictate future prognosis in pediatric patients with cirrhosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available